Surgical Innovations Group plc
SUN.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | £0 | £0 | £0 | £0 |
| % Growth | -0.6% | 5.9% | 24.3% | – |
| Cost of Goods Sold | £0 | £0 | £0 | £0 |
| Gross Profit | £0 | £0 | £0 | £0 |
| % Margin | 28.8% | 28.7% | 34.6% | 34.3% |
| R&D Expenses | £0 | £0 | £0 | £0 |
| G&A Expenses | £0 | £0 | £0 | £0 |
| SG&A Expenses | £0 | £0 | £0 | £0 |
| Sales & Mktg Exp. | £0 | £0 | £0 | £0 |
| Other Operating Expenses | £0 | £0 | £0 | £0 |
| Operating Expenses | £0 | £0 | £0 | £0 |
| Operating Income | -£0 | -£0 | £0 | -£0 |
| % Margin | -6.6% | -5% | 0.4% | -5.3% |
| Other Income/Exp. Net | -£0 | -£0 | -£0 | -£0 |
| Pre-Tax Income | -£0 | -£0 | -£0 | -£0 |
| Tax Expense | -£0 | -£0 | -£0 | -£0 |
| Net Income | -£0 | -£0 | £0 | -£0 |
| % Margin | -16.3% | -4.2% | 2.3% | -5% |
| EPS | -0.002 | -0.001 | 0 | -0.001 |
| % Growth | -320% | -266.7% | 160% | – |
| EPS Diluted | -0.002 | -0.001 | 0 | -0.001 |
| Weighted Avg Shares Out | 1 | 1 | 1 | 1 |
| Weighted Avg Shares Out Dil | 1 | 1 | 1 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | £0 | £0 | £0 | £0 |
| Interest Expense | £0 | £0 | £0 | £0 |
| Depreciation & Amortization | £0 | £0 | £0 | £0 |
| EBITDA | -£0 | £0 | £0 | £0 |
| % Margin | -0.8% | 1.3% | 5.5% | 2.7% |